Copertina

Baseline Characteristics and Self‐Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO‐2) Cohort

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Georgene E. Hergenroeder, Kevin J. Psoter, Cynthia D. Brown, Josh Ostrenga, Christine Ford, Lisa Bendy, Bradley H. Rosen, Nell Meosky Luo, Connie Zhang, Kathryn A. Sabadosa, Clement L. Ren
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Pulmonology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Current Status and the Need for CFTR Modulator Therapy in Cystic Fibrosis Patients in Mainland China: A Case Report and Literature Review
di: Yuxiao Sun, et al.
Pubblicazione: (2026)

Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function?
di: C. M. López Cárdenes, et al.
Pubblicazione: (2026)

Bridging the Gap in Neonatal Care: Evaluating AI Chatbots for Chronic Neonatal Lung Disease and Home Oxygen Therapy Management
di: Weiqin Liu, et al.
Pubblicazione: (2025)

Sirolimus Therapy in Generalized Lymphatic Anomaly With Tuberculosis: A Case Report
di: Kamal K. Singhal, et al.
Pubblicazione: (2026)

MLPA‐Detected CFTR Exon Deletions in Children With Inconclusive CFTR Sequencing: A Single‐Center Experience From Türkiye
di: Sanem Eryılmaz Polat, et al.
Pubblicazione: (2026)

Clinical outcomes at 9–10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome
di: Brian J. Carroll, et al.
Pubblicazione: (2024)

Exploring perceptions of and decision‐making about CFTR modulators
di: Lee Landess, et al.
Pubblicazione: (2024)

Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF
di: Michael S. Schechter, et al.
Pubblicazione: (2024)

Pulmonary Alveolar Proteinosis Secondary to ADA‐SCID Successfully Treated With Gene Therapy: A Case Report
di: Cristina de Manuel Gómez, et al.
Pubblicazione: (2026)

Interventional Therapy for a Child With Tracheal Lobular Capillary Hemangioma: A Case Report and Literature Review
di: Lijun Wang, et al.
Pubblicazione: (2025)

CFTR Modulators in Brazil: Not for Everyone—A Comparison of Ineligibility Across Different Regions
di: Edna Lúcia D' Souza, et al.
Pubblicazione: (2026)

Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
di: Tyler Shugg, et al.
Pubblicazione: (2025)

Usefulness of Telemonitoring in Respiratory Deterioration in a Patient Treated With Home High‐Flow Nasal Therapy
di: Jean-Michel Arnal, et al.
Pubblicazione: (2025)

Discharge Practice Variability in Pediatric Chronic Home Invasive Ventilation
di: Guillermo Beltran‐Ale, et al.
Pubblicazione: (2025)

Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis
di: CM. López Cárdenes, et al.
Pubblicazione: (2024)

Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey
di: Birce Sunman, et al.
Pubblicazione: (2025)

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants
di: Emily Mitchell, et al.
Pubblicazione: (2024)

The rebound effect: Reoccurrence of nasal polyps following discontinuation of a CFTR modulator in a patient with cystic fibrosis sinus disease
di: Brittany A. Wright, et al.
Pubblicazione: (2024)

Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes
di: Denise M. Kay, et al.
Pubblicazione: (2024)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
di: Bulent Karadag
Pubblicazione: (2026)

Remission in Children Receiving Biologic Therapy for Severe Asthma
di: Eilidh Bruce, et al.
Pubblicazione: (2025)

Nasal High‐Flow Therapy Versus Low‐Flow Oxygen Therapy Post‐Discharge in Infants With Bronchopulmonary Dysplasia: A Retrospective Observational Study
di: Alessia Mariani, et al.
Pubblicazione: (2024)

Pediatric Provider Experiences With Single Maintenance and Reliever Therapy (SMART)
di: Michelle K. Trivedi, et al.
Pubblicazione: (2026)

Lung Function in a Multiethnic U.S. Cohort of Adolescents and Adults Born Preterm in the New BPD Era
di: Nataly J. Sanchez‐Solano, et al.
Pubblicazione: (2025)

Concordance Between Asthma Symptom Reports and Objective Lung Function, and Associations With Sleep Outcomes in Urban Children
di: Daniella Teape, et al.
Pubblicazione: (2025)

New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR‐related metabolic syndrome
di: Saroj Choudhary, et al.
Pubblicazione: (2024)

The Therapeutic Role of Orofacial Myofunctional Therapy in Childhood Residual Obstructive Sleep Apnea
di: Maoyu Ye, et al.
Pubblicazione: (2025)

Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
di: Jeremy P. Tervo, et al.
Pubblicazione: (2025)

Expanding the Impact of New Cystic Fibrosis Therapies in Low‐ and Middle‐Income Countries
di: Eitan Kerem
Pubblicazione: (2024)

Elexacaftor/Tezacaftor/Ivacaftor Effect on a Patient With Rare Compound Heterozygous CFTR Splice Variant Genotype C.[1393‐1G>A;2988+1G>A]
di: Maria Moustaki, et al.
Pubblicazione: (2025)

Lung T1‐MRI and Multi‐Breath Washout Detect Longitudinal Changes in Children 6–11 Years Old After Beginning Elexacaftor/Tezacaftor/Ivacaftor (ETI) Therapy
di: Samya Z. Nasr, et al.
Pubblicazione: (2026)

Pediatric Asthma Therapy Assessment Questionnaire for the Brazilian population: Cross‐cultural adaptation and measurement properties
di: Thayla Amorim Santino, et al.
Pubblicazione: (2024)

Comparison of Short‐ vs Long‐Course Antibiotic Therapy for Children With Tracheitis Associated With an Artificial Airway
di: Tracy N. Zembles, et al.
Pubblicazione: (2026)

Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor‐Tezacaftor‐Ivacaftor Therapy
di: Kimberly Pasley, et al.
Pubblicazione: (2024)

Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy
di: Julianna Bailey, et al.
Pubblicazione: (2026)

Correlation of High Resolution CT Findings With Lung Function in Adolescents With Perinatally Acquired HIV on Anti‐Retroviral Therapy
di: Du Plessis Anne‐Marie, et al.
Pubblicazione: (2025)

Effects of Prolonged Antibiotic Therapy in Lung Abscesses—Analysis of Case Series
di: Agata Anna Lewandowska, et al.
Pubblicazione: (2025)

Relating Improvement in Gastrointestinal (CFAbd‐Score © ) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF Patients
di: Jochen G. Mainz, et al.
Pubblicazione: (2026)

Impact of Duration of Nasal High Flow Therapy on Respiratory Outcomes in Very Preterm Infants: A Propensity Score Analysis
di: Emanuela Zannin, et al.
Pubblicazione: (2025)

Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
di: Sean Coyne, et al.
Pubblicazione: (2024)